Pherin: A nose for innovation

Surrounded by an industry spawning complex technologies in high throughput screening, genomics or transplantation comes Pherin Corp., a company with a straightforward approach to drug delivery using mother nature's own equipment, the nose.

Shunning traditional systemic drug delivery approaches and relying on the body's own internal message system, Pherin's product development centers on the functioning of the human vomeronasal organ (VNO), which is found in the nose. The company's pharmaceutical compounds - called vomeropherins- are designed to be used topically within the nasal passage where they trigger a nerve impulse to the hypothalamus, the control center in the brain that acts as the link between the endocrine and nervous systems, regulating a host of physiological functions.